Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in Haiti

NCT00120510 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

816

Enrollment

NIH

Sponsor class

Conditions

HIV Infections
Tuberculosis

Interventions

DRUG: Efavirenz
DRUG: Lamivudine/Zidovudine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)